PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
370.05%
Net income growth above 1.5x JD's 10.51%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-2.70%
Negative yoy D&A while JD is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
28.17%
Deferred tax of 28.17% while JD is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-28.17%
Negative yoy SBC while JD is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
11009.33%
Working capital change of 11009.33% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
-21.25%
AR is negative yoy while JD is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
31.16%
Inventory growth of 31.16% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
504.25%
AP growth of 504.25% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
418.96%
Growth of 418.96% while JD is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
366.40%
Some yoy increase while JD is negative at -301.39%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
1206.36%
Some CFO growth while JD is negative at -173.37%. John Neff would note a short-term liquidity lead over the competitor.
-13.45%
Negative yoy CapEx while JD is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-289.24%
Negative yoy acquisition while JD stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-68.96%
Negative yoy purchasing while JD stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
955.91%
Liquidation growth of 955.91% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
84.12%
Less 'other investing' outflow yoy vs. JD's 248.67%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
255.78%
Investing outflow well above JD's 230.06%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-5943.99%
We cut debt repayment yoy while JD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-26.06%
Negative yoy issuance while JD is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.